07:00 , Mar 22, 2010 |  BC Week In Review  |  Company News

bioMerieux sales and marketing update

bioMerieux launched chromID VRE in the U.S. The test has 510(k) clearance for qualitative detection of Enterococcus faecium and E. faecalis showing acquired resistance to vancomycin in stool specimens. bioMerieux already markets the chromID MRSA...
08:00 , Nov 2, 2009 |  BC Week In Review  |  Company News

bioMerieux sales and marketing update

bioMerieux launched its chromID MRSA chromogenic culture medium in the U.S. to detect methicillin-resistant Staphylococcus aureus (MRSA). bioMerieux S.A. (Euronext:BIM), Marcy l'Etoile, France   Business: Diagnostic  ...